Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases

The original version of the article unfortunately contained a couple of errors. In ‘methods’ section, in ‘Outcomes’ subsection, the sentence 'Endoscopic remission was defined as an SESCD ≤ 2 in patients with CD and an EMS ≤ 2 in UC patients while off corticosteroids.’

Retraction Note: CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells

This article [1] is retracted at the request of Editor-in-Chief.

Practicing Gastroenterology at the Veterans Administration: Serving the Most Deserving


Mass Transition: From Cecal Mass to Small Bowel Ischemia


Letter to Editor on “Selective Trans-Catheter Coil Embolization of Cystic Duct Stump in Postcholecystectomy Bile Leak”


Enteroscopy‑ERCP Cannot Replace the Role of Percutaneous Transhepatic Biliary Drains in Treating Biliary‑Enteric Anastomotic Strictures


DDS Profile: Maria T. Abreu, MD


Delayed Realization of Enhanced Caregiver Burden in Gastroparesis Patients


Taking a Load Off Diagnosing Constipation: Utility of the Plain Film


Detecting Pancreatic Carcinoma in the Setting of Idiopathic Pancreatitis and Negative Cross-Sectional Imaging: Why EUS Is Useful